Latest Intelligence on Vaccines in Brazil

Select information type

Refine your search

Search tips

Published within

« | 1 | » »|

Type Product title / description Pub Price

GSK: another price-reduction deal in emerging markets

As part of its ongoing attempts to penetrate the emerging markets, GlaxoSmithKline has signed an innovative pneumococcal vaccines deal in Brazil, which also includes a technology transfer and R&D investment. As well as boosting the pharma giant's volume in this rapidly growing and commercially attractive market, the deal is expected to increase access to vaccines in the country.

Published By Datamonitor
29 Sep 2009

« | 1 | » »|

No help is available.